Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 14, 2026 | Moda Health | Unloxcyt (cosibelimab-ipdl) | Criteria changed |
| May 14, 2026 | Moda Health | Ultomiris (ravulizumab-cwvz) | Criteria changed |
| May 14, 2026 | Moda Health | Tzield (teplizumab-mzwv) | Criteria changed |
| May 14, 2026 | Moda Health | Natalizumab: (Tysabri; Tyruko) | Criteria changed |
| May 14, 2026 | Moda Health | Trodelvy (sacituzumab govitecan-hziy) | Criteria changed |
| May 14, 2026 | Moda Health | Trogarzo (ibalizumab-uiyk) | Criteria changed |
| May 14, 2026 | Moda Health | Tremfya (guselkumab) | Criteria changed |
| May 14, 2026 | Moda Health | Tocilizumab: Actemra; Tofidence; Tyenne; Avtozma; Tocilizumab-anoh§; Tocilizumab-aazg§ | Criteria changed |
| May 14, 2026 | Moda Health | Tivdak (tisotumab vedotin-tftv) | Criteria changed |
| May 14, 2026 | Moda Health | Tezspire (tezepelumab-ekko) | Criteria changed |
| May 14, 2026 | Moda Health | Tevimbra™ (tislelizumab-jsgr) | Criteria changed |
| May 14, 2026 | Moda Health | Tepezza (teprotumumab-trbw) | Criteria changed |
| May 14, 2026 | Moda Health | Tecvayli (teclistamab-cqyv) | Criteria changed |
| May 14, 2026 | Moda Health | Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) | Criteria changed |
| May 14, 2026 | Moda Health | Tecentriq (atezolizumab) | Criteria changed |
| May 14, 2026 | Moda Health | Tecartus (brexucabtagene autoleucel) | Criteria changed |
| May 14, 2026 | Moda Health | Talvey (talquetamab-tgvs) | Criteria changed |
| May 14, 2026 | Moda Health | Sylvant (siltuximab) | Criteria changed |
| May 14, 2026 | Moda Health | Syfovre (pegcetacoplan) | Criteria changed |
| May 14, 2026 | Moda Health | Susvimo (ranibizumab) | Criteria changed |
| May 14, 2026 | Moda Health | Standard Half-life Factor IX Products: AlphaNine SD, BeneFIX, Ixinity, MonoNine, Profilnine SD, and Rixubis | Criteria changed |
| May 14, 2026 | Moda Health | Standard Half-life Factor VIII Products: Advate, Afstyla, Hemofil M, Koate DVI, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, and Xyntha | Criteria changed |
| May 14, 2026 | Moda Health | Spinraza (nusinersen) | Criteria changed |
| May 14, 2026 | Moda Health | Spevigo (spesolimab) | Criteria changed |
| May 14, 2026 | Moda Health | Skysona (elivaldogene autotemcel) | Criteria changed |
| May 14, 2026 | Moda Health | Skyrizi (risankizumab-rzaa) | Criteria changed |
| May 14, 2026 | Moda Health | Signifor LAR (pasireotide) | Criteria changed |
| May 14, 2026 | Moda Health | SCIG (immune globulin SQ): Hizentra, Gammagard Liquid, Gamunex-C, Gammaked, HyQvia, Cuvitru, Cutaquig, Xembify | Criteria changed |
| May 14, 2026 | Moda Health | Sarclisa (isatuximab-irfc) | Criteria changed |
| May 14, 2026 | Moda Health | Saphnelo (anifrolumab-fnia) | Criteria changed |
| May 14, 2026 | Moda Health | Rytelo (imetelstat) | Criteria changed |
| May 14, 2026 | Moda Health | Rystiggo (rozanolixizumab-noli) | Criteria changed |
| May 14, 2026 | Moda Health | Rylaze (asparaginase Erwinia chrysanthemi (recombinant)-rywn) | Criteria changed |
| May 14, 2026 | Moda Health | Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) | Criteria changed |
| May 14, 2026 | Moda Health | Ryzneuta (efbemalenograstim alfa-vuxw) | Criteria changed |
| May 14, 2026 | Moda Health | Ruconest (C1 Esterase Inhibitor [recombinant]) | Criteria changed |
| May 14, 2026 | Moda Health | Roctavian (valoctocogene roxaparvovec-rvox) | Criteria changed |
| May 14, 2026 | Moda Health | Rivfloza (nedosiran) | Criteria changed |
| May 14, 2026 | Moda Health | Rituxan Hycela (rituximab and hyaluronidase human) | Criteria changed |
| May 14, 2026 | Moda Health | Revcovi (elapegademase-lvlr) | Criteria changed |
| May 14, 2026 | Moda Health | Reblozyl (luspatercept-aamt) | Criteria changed |
| May 14, 2026 | Moda Health | Ranibizumab: Byooviz Cimerli Lucentis Nufymco | Criteria changed |
| May 14, 2026 | Moda Health | Radicava (edaravone) | Criteria changed |
| May 14, 2026 | Moda Health | Qfitlia (fitusiran) | Criteria changed |
| May 14, 2026 | Moda Health | Provenge (sipuleucel-T) | Criteria changed |
| May 14, 2026 | Moda Health | Proleukin (aldesleukin, IL-2) | Criteria changed |
| May 14, 2026 | Moda Health | Poteligeo (mogamulizumab-kpkc) | Criteria changed |
| May 14, 2026 | Moda Health | Portrazza (necitumumab) | Criteria changed |
| May 14, 2026 | Moda Health | Pombiliti (cipaglucosidase alfa-atga) | Criteria changed |
| May 14, 2026 | Moda Health | Polivy (polatuzumab vedotin-piiq) | Criteria changed |